James joined the IFPMA as Executive Director of Global Health in January 2021, where he is responsible for leading the work on priorities in global health. This includes industry’s policy and advocacy on pandemic preparedness, antimicrobial resistance (AMR) and global access to medicines and vaccines.
In his previous role as Head of Corporate Government Affairs at GSK, James led GSK’s strategic engagement with the UK Government and was a member of the Life Science Strategy Board and Vice-Chair of Business at OECD’s Healthcare Committee. He led GSK’s work on AMR and advised on AMR policy development at the WHO, UN, EU Commission and National Governments.
He was also in the Founding team of the AMR Action Fund and led the development of the Davos Declaration and UNGA Industry AMR Roadmap.
See our Cookie Privacy Policy Here
